Impact of age, comorbidity, and polypharmacy on the efficacy and safety of edoxaban for the treatment of venous thromboembolism: An analysis of the randomized, double-blind Hokusai-VTE trial

Bibliographic Details
Title: Impact of age, comorbidity, and polypharmacy on the efficacy and safety of edoxaban for the treatment of venous thromboembolism: An analysis of the randomized, double-blind Hokusai-VTE trial
Authors: Vanassche, Thomas, Verhamme, Peter, Wells, Philip S., Segers, Annelise, Ageno, Walter, Brekelmans, Marjolein P.A., Chen, Cathy Z., Cohen, Alexander T., Grosso, Michael A., Medina, Andria P., Mercuri, Michele F., Winters, Shannon M., Zhang, George, Weitz, Jeffrey I., Raskob, Gary E., Büller, Harry R.
Source: In Thrombosis Research February 2018 162:7-14
Database: ScienceDirect
More Details
ISSN:00493848
DOI:10.1016/j.thromres.2017.12.005
Published in:Thrombosis Research
Language:English